3 ms·
The drug was then unaffordable regardless of intent. You can't separate the two. Again, your solution doesn't stop this.
by drzaiusapelord 10y ago
The drug was then unaffordable regardless of intent. You can't separate the two. Again, your solution doesn't stop this.
- klodolph 10y ago> Again, your solution doesn't stop this. I'm honestly quite confused here. What solution, exactly, are you talking about? I don't remember proposing a solution. In the Shkreli case, the drug price was raised in September 2015, and a cheap replacement was available on the market in October 2015 from a different company.
- drzaiusapelord 10y agoMany insurers didn't cover the competing product, so the real life lag time for healthcare consumers was either much longer or they simply had to pay the full cash price out of pocket.